Key facts
- This page summarizes Robert Kramer's Form 4 filing for Emergent BioSolutions Inc. (EBS).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 10 Feb 2023, 19:36.
Robert Kramer - 08 Feb 2023 Form 4 Insider Report for Emergent BioSolutions Inc. (EBS)
- Reporting relationship
- President and CEO, Director
- Issuer ticker
- EBS
- Reported as of
- 08 Feb 2023
- Net transaction value
- -$65,508
- SEC form
- 4
- Accepted by SEC
- 10 Feb 2023, 19:36:09 UTC
- Prior SEC filing
- 02 Mar 2022
- Next SEC filing
- 27 Feb 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Jennifer Lynn Fox, Attorney-in-fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Robert Kramer filed Form 4 for Emergent BioSolutions Inc. (EBS) on 10 Feb 2023.
Change
- Previous filing in this sequence was filed on 02 Mar 2022.
- Current net transaction value: -$65,508.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
EBS
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +278
- Change %
- +0.24%
- Price
- $0.000000
- Shares after
- 114,487
- Date
- 08 Feb 2023
- Ownership
- Direct
- Footnotes
- F1
EBS
transaction
Common Stock
Tax liability
- Transaction value
- $65,508
- Shares
- -4,944
- Change %
- -4.3%
- Price
- $13.25
- Shares after
- 109,543
- Date
- 08 Feb 2023
- Ownership
- Direct
- Footnotes
- F2
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 2 footnotes
Footnote F1
Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 16,961 shares of common stock, which is in excess of the 16,683 shares previously reported on February 25, 2020.
Footnote F2
Represents shares of common stock withheld to pay taxes.